PrJSC Severodonetsk Azot, part of the group of nitrogen business enterprises Group DF, is preparing to produce oxygen for medical use and has already submitted the necessary documentation package to the State Expert Center of the Ministry of Health.
“All organizational issues related to permits must be resolved as quickly as possible. The region has a difficult epidemic situation with COVID-19,” the Group DF said in a Tuesday press release, quoting Board Chairman of Severodonetsk Azot Leonid Buhaev from a working meeting with Head of the Luhansk Regional Administration Serhiy Haidai.
The company said that it has already received a license from the State Service of Ukraine on Medicines and Drug Control for the production and sale of oxygen for medical use.
According to the release, the production capacity of the air separation workshop is 500 cubic meters of oxygen for medical use per hour. According to Haidai, with the resumption of production of medical oxygen at Azot, the region will be fully provided with the necessary number of cylinders for the treatment of seriously ill patients with COVID-19.
Severodonetsk Azot is one of the largest Ukrainian chemical enterprises. It has been part of Dmytro Firtash’s Group DF since 2011. The core business of the enterprise is the production of mineral nitrogen fertilizers.
MEDICAL OXYGEN, SEVERODONETSK AZOT
